| Literature DB >> 32544310 |
Heather M Snyder1, Lisa J Bain2, Adam M Brickman3, Maria C Carrillo1, Anna J Esbensen4, Joaquin M Espinosa5, Fabian Fernandez6, Juan Fortea7,8, Sigan L Hartley9, Elizabeth Head10, James Hendrix11, Priya S Kishnani12, Florence Lai13, Patrick Lao14, Cynthia Lemere15, William Mobley16, Elliott J Mufson17, Huntington Potter18, Shahid H Zaman19, Ann-Charlotte Granholm20,21, H Diana Rosas22, Andre Strydom23, Michelle Sie Whitten24, Michael S Rafii25.
Abstract
Improved medical care of individuals with Down syndrome (DS) has led to an increase in life expectancy to over the age of 60 years. In conjunction, there has been an increase in age-related co-occurring conditions including Alzheimer's disease (AD). Understanding the factors that underlie symptom and age of clinical presentation of dementia in people with DS may provide insights into the mechanisms of sporadic and DS-associated AD (DS-AD). In March 2019, the Alzheimer's Association, Global Down Syndrome Foundation and the LuMind IDSC Foundation partnered to convene a workshop to explore the state of the research on the intersection of AD and DS research; to identify research gaps and unmet needs; and to consider how best to advance the field. This article provides a summary of discussions, including noting areas of emerging science and discovery, considerations for future studies, and identifying open gaps in our understanding for future focus.Entities:
Keywords: Alzheimer's disease; Down syndrome; trisomy; vascular contributions
Mesh:
Substances:
Year: 2020 PMID: 32544310 PMCID: PMC8865308 DOI: 10.1002/alz.12112
Source DB: PubMed Journal: Alzheimers Dement ISSN: 1552-5260 Impact factor: 16.655